Torrent Pharma Sets Feb 19, 2026 as Record Date for Interim Dividend
Torrent Pharmaceuticals Limited has set February 19, 2026, as the record date for interim dividend payment. The Board will decide on the dividend declaration in a meeting on February 13, 2026. This is for equity shareholders of ₹5 each.
This is a standard corporate action related to dividend distribution and does not represent a significant change in the company's business operations or financial performance.
The announcement is a routine procedural intimation regarding a record date for a potential interim dividend. It does not contain information that would immediately suggest a positive or negative financial outlook.
Torrent Pharmaceuticals Limited has announced that Thursday, February 19, 2026, has been fixed as the record date for the purpose of payment of interim dividend. This decision is contingent upon the Board of Directors declaring the dividend at their upcoming meeting scheduled for Friday, February 13, 2026.
The record date will be used to determine the names of shareholders eligible to receive the interim dividend, if declared by the Board. The company has submitted this intimation in accordance with Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
What to do with a filing like this
Torrent Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Torrent Pharmaceuticals Limited. Read the original for the full detail.